Weekly Digest – March 2026 Weekly Digest – March 2026 10 March 2026: ProstACT Global Phase 3 study (part 1) achieves primary objectives Telix Pharmaceuticals announced that Part 1 of the global Phase 3 ProstACT Global trial evaluating its investigational […]